Gelteq Limited Ordinary Shares Stock (NASDAQ:GELS)
Previous Close
$1.24
52W Range
$0.77 - $5.50
50D Avg
$1.33
200D Avg
$1.63
Market Cap
$12.13M
Avg Vol (3M)
$1.30M
Beta
-4.93
Div Yield
-
GELS Company Profile
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.